Sequent Scientific Limited (SEQUENT.NS)NSE



As of March 02 12:30PM

Currency In INR

Sequent Scientific Limited




91 22 4111 4777




Drug Manufacturers—Specialty & Generic



First IPO Date

March 10, 2016

Key Executives

NameTitlePayYear Born
Mr. Rajaram NarayananMD, Chief Executive Officer & Director49.17M1968
Mr. Sharat NarasapurJoint MD & Director19.36M1966
Mr. Phillip TrottSecretary, Compliance Off., Assoc. Vice President, Head of Legal, Secretarial & Compliance and Chief Risk Off.0N/A
Mr. Prasad LadVice President of HR & Administration0N/A
Mr. Ravi NairExecutive Vice President of Human Resources & Administration0N/A
Mr. Ramesh Kumar PillaiCorporate Vice President of Ra Qa and Technical Services01965
Mr. Saurav BhalaChief Financial Officer0N/A
Mr. Abhishek SinghalHead of Investor Relations0N/A


Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.